Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
09:10:41 EDT Sun 08 Sep 2024
Enter Symbol
or Name
USA
CA



Forgot password?
Trouble logging in?
Login ID:
Password:
Save

News for C:NUMI from 2023-09-07 to 2024-09-06 - 51 items News ReleasesIn The NewsOther CAUS
DateSymCompanyPriceTypeHeadline
2024-08-12 12:30C:NUMINuminus Wellness Inc0.045News ReleaseNuminus comments on FDA decision over MDMA application
2024-07-11 16:30C:NUMINUMINUS WELLNESS INC. J0.045News ReleaseNuminus Wellness Inc. Announces Third Quarter Fiscal 2024 Results
2024-07-11 16:17C:NUMINuminus Wellness Inc0.045SEDAR Interim MD & ASEDAR Interim MD & A
2024-07-11 16:11C:NUMINuminus Wellness Inc0.04SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-07-10 18:41C:NUMINuminus Wellness Inc0.04News ReleaseNuminus to release Q3 results, host call July 11
2024-06-24 17:35C:NUMINuminus Wellness Inc0.05News ReleaseNuminus director Wong resigns
2024-06-20 10:05C:NUMINuminus Wellness Inc0.055News ReleaseNuminus signs LOI for MedBright AI acquisition
2024-06-07 21:26C:NUMINuminus Wellness Inc0.05News ReleaseNuminus clarifies disclosure in May 30 news releases
2024-06-07 09:12C:NUMINuminus Wellness Inc0.045News ReleaseNuminus's MDMA therapy not approved by FDA committee
2024-05-31 19:53C:NUMINuminus Wellness Inc0.065News ReleaseNuminus shareholders approve all matters at AGM
2024-05-30 14:39C:NUMINuminus Wellness Inc0.065News ReleaseNuminus Wellness to roll out membership program
2024-05-30 14:26C:NUMINuminus Wellness Inc0.065News ReleaseNuminus to host Cybin trial on CYB003 at Cedar Clinical
2024-05-30 10:03C:NUMINuminus Wellness Inc0.065News ReleaseNuminus approved for MDMA-assisted group therapy trial
2024-05-07 10:42C:NUMINuminus Wellness Inc0.075News ReleaseNuminus to close clinics, work with Field Trip Health
2024-04-17 10:39C:NUMINuminus Wellness Inc0.07News ReleaseNuminus's Cedar chosen as Cybin study research site
2024-04-15 12:44C:NUMINuminus Wellness Inc0.075News ReleaseNuminus Wellness to focus on U.S. operations
2024-04-12 20:30C:NUMINuminus Wellness Inc0.10News ReleaseNuminus omits Q2 net P&L in NR, talks revenue
2024-04-12 16:23C:NUMINuminus Wellness Inc0.10SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-04-12 16:23C:NUMINuminus Wellness Inc0.10SEDAR Interim MD & ASEDAR Interim MD & A
2024-04-09 10:37C:NUMINuminus Wellness Inc0.115News ReleaseNuminus to release Q2 2024 results April 15
2024-03-26 13:01C:NUMINuminus Wellness Inc0.095News ReleasePharmala Biotech to provide LaNeo MDMA to Numinus
2024-03-20 09:54C:NUMINuminus Wellness Inc0.095News ReleaseNuminus Wellness submits clinical trial application
2024-03-12 10:03C:NUMINuminus Wellness Inc0.11News ReleaseNuminus moves AGM to May 21, Garner to retire
2024-03-08 09:24C:NUMINuminus Wellness Inc0.12News ReleaseNuminus congratulates Mind Medicine on MM120 trial
2024-02-16 16:48C:NUMINuminus Wellness Inc0.12Prospectus ApprovedNuminus Wellness closes prospectus offering
2024-02-16 11:10C:NUMINuminus Wellness Inc0.11News ReleaseNuminus Wellness closes $6-million public offering
2024-02-14 14:29C:NUMINuminus Wellness Inc0.115MiscellaneousNuminus Wellness offering delayed
2024-02-14 13:54C:NUMINuminus Wellness Inc0.115News ReleaseNuminus Wellness cheers Lykos's FDA NDA acceptance
2024-02-09 23:15C:NUMINuminus Wellness Inc0.115MiscellaneousNuminus Wellness offering delayed
2024-02-08 21:57C:NUMINuminus Wellness Inc0.115Prospectus ApprovedNuminus Wellness to list additional shares Feb. 12
2024-02-02 07:57C:NUMINuminus Wellness Inc0.14Resume TradingNuminus Wellness resuming at the open
2024-02-01 16:46C:NUMINuminus Wellness Inc0.14News ReleaseNuminus Wellness arranges $6-million bought deal
2024-02-01 16:29C:NUMINuminus Wellness Inc0.14Halt TradingNuminus Wellness halted at 1:27 p.m. PT
2024-02-01 15:21C:NUMINuminus Wellness Inc0.14News ReleaseNuminus Wellness corrects asset divestment
2024-02-01 10:32C:NUMINuminus Wellness IncNews ReleaseNuminus agrees to unload Alto Neuroscience holdings
2024-01-15 17:07C:NUMINuminus Wellness Inc0.175News ReleaseNuminus Wellness loses $4.35-million in fiscal Q1
2024-01-15 14:27C:NUMINuminus Wellness Inc0.175SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-01-15 14:27C:NUMINuminus Wellness Inc0.175SEDAR Interim MD & ASEDAR Interim MD & A
2024-01-02 17:23C:NUMINuminus Wellness Inc0.12News ReleaseNuminus Wellness to release Q1 results Jan. 15
2023-12-15 11:31C:NUMINuminus Wellness Inc0.105News ReleaseNuminus's Cedar chosen as Beckley study research site
2023-12-13 10:43C:NUMINuminus Wellness Inc0.11News ReleaseNuminus cheers MAPS's FDA NDA for PTSD therapy
2023-11-29 22:42C:NUMINuminus Wellness Inc0.105SEDAR MD & ASEDAR MD & A
2023-11-29 22:31C:NUMINuminus Wellness Inc0.105SEDAR Annual Information FormSEDAR Annual Information Form
2023-11-29 22:26C:NUMINuminus Wellness Inc0.105SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2023-11-29 17:09C:NUMINuminus Wellness Inc0.105News ReleaseNuminus Wellness loses $29.94-million in 2023
2023-11-21 13:12C:NUMINuminus Wellness Inc0.11News ReleaseNuminus Wellness to release fiscal 2023 results Nov. 29
2023-10-05 18:41C:NUMINuminus Wellness Inc0.165Prospectus ApprovedNuminus Wellness to list additional shares on TSX
2023-10-03 12:16C:NUMINuminus Wellness Inc0.17News ReleaseNuminus details psychedelic program for mental distress
2023-09-25 19:26C:NUMINuminus Wellness Inc0.185News ReleaseNuminus arranges $10-million at-the-market program
2023-09-19 12:02C:NUMINuminus Wellness Inc0.205News ReleaseNuminus cheers MAPS phase 3 MDMA-AT results
2023-09-18 19:08C:NUMINuminus Wellness Inc0.225News ReleaseNuminus to end Numinus Bioscience operations